HOME >> MEDICINE >> NEWS
Heart devices, procedures evaluated across patient populations

ATLANTA, GA (March 13, 2006) -- Studies investigating procedure and device efficacy across patient populations have found varying results with regard to Implantable Cardioverter Defibrillators (ICD) and defibrillators. According to research presented today at the American College of Cardiology's 55th Annual Scientific Session, new studies take a closer look at women, minorities and athletes, as well as recall issues with ICDs. ACC.06 is the premier cardiovascular medical meeting, bringing together over 30,000 cardiologists to further breakthroughs in cardiovascular medicine.

"Consistent re-evaluation of commonly used devices and procedures ensures their efficacy across patient populations and helps identify new patient groups who may benefit from these procedures," said Douglas P. Zipes, M.D., Indiana University School of Medicine. "These data illuminates critical gaps in procedure and device effectiveness as well as procedural protocol across gender, race and age."

Does Gender Alter the Efficacy of Implantable Cardioverter Defibrillators? (Abstract 947-129)

Implantable Cardioverter Defibrillators (ICD) can be a life saving therapy for patients suffering from cardiovascular disease with an increased risk of fatal arrhythmias. However, the majority of studies involve male patients and, consequently, much less is known about ICD efficacy in women. Researchers from Hartford Hospital in Connecticut and the University of Connecticut investigated the use of ICDs in women and found that females have significantly lower survival rates with this procedure than their male counterparts.

The study authors reviewed previous studies on ICDs and evaluated five trials that met the following criteria: controlled trial versus standard of care, ICD as primary prevention, and available data on risk of death for both male and female patients. In total, ICD therapy reduced the risk of death by 24 percent in men, but only by 12 percent in
'"/>


13-Mar-2006


Page: 1 2 3 4 5

Related medicine news :

1. Drug-eluting stent controversy explored in the American Heart Hospital Journal
2. Heart-failure patients benefit from pharmacist care
3. Study offers clues to Broken Heart Syndrome
4. Heart Failure 2007
5. Heart failure medication does not improve survival, compared to more widely used medication
6. UCLA neurologist honored with American Heart Associations Stroke Council Award
7. Heart failure: Mayo Clinic reveals abnormality in filling of the heart is frequent culprit
8. Heart catheters do not benefit patients
9. Heart Rhythm Society publishes final recommendations for heart patients
10. Heartburn drug may help to slow progression of chronic heart failure
11. Heart failure drugs may be beneficial for patients with hardening of the arteries

Post Your Comments:
*Name:
*Comment:
*Email:


(Date:8/31/2020)... ... 31, 2020 , ... Cardiothoracic surgeons at Allegheny General Hospital ... Mellon University (CMU) to develop a new heart monitoring device designed to serve ... , The AGH/CMU team was recently awarded a “Trailblazer” grant from the National ...
(Date:8/31/2020)... ... August 31, 2020 , ... Want to get moving, break ... Alliance Research Foundation (CPARF) is thrilled to launch its fourth annual STEPtember campaign in ... virtual challenge, STEPtember meets everyone wherever they are at this moment — encouraging people ...
(Date:8/31/2020)... ... 2020 , ... The pandemic and topsy-turvy economic outlook continues to put financial strain on many ... to trim the fat from our monthly expenses and put more into savings, if possible. ... you have a financial safety net in place in case something were to happen to ...
(Date:8/31/2020)... ... August 31, 2020 , ... Bonde Innovations, LLC, a venture-backed ... heart failure, today announced that the company has been awarded a Phase 1 ... National Heart, Lung, and Blood Institute of the National Institutes of Health (NIH). ...
(Date:8/28/2020)... ... August 28, 2020 , ... The 15 scholarships ... Lighthouse Health & Wellness mobile app and web-portal. NCPCV received a 2020 grant ... awards grants each year to organizations, such as Destination Imagination, which support and ...
Breaking Medicine News(10 mins):
(Date:9/1/2020)... SANTA CLARA, Calif. (PRWEB) , ... September 01, ... ... diagnostics, and analytical laboratory technologies, will host the Agilent Science and Technology ... , During this two-day symposium, Agilent will open a suite of Live webinars ...
(Date:9/1/2020)... ... September 01, 2020 , ... Neil Oberfeld of global ... to the Board of Trustees and committee chair of the Governance Committee for ... Denver-based nonprofit organization that fights for the education, health, and financial stability of ...
(Date:9/1/2020)... ... , ... Breast and ovarian cancers are common diseases that affect many women. ... (about 7,500 women per year) and 10% of ovarian cancers (about 2,000 women per ... are detectable in the Women’s Excellence Genetic Testing Program. , Dr. Jonathan Zaidan, MD, ...
Breaking Medicine Technology:
Cached News: